There is an urgent need for a pharmacological agent that can specifically and safely correct the shared metabolic pathology, ideally by acting at both central (e.g., controlling appetite and cravings) and peripheral (e.g., improving insulin sensitivity, reducing hepatic fat and inflammation) levels to support and enhance existing behavioral strategies, thereby lowering the risk of advanced liver disease development across metabolic and alcoholic etiologies
cardiovascular outcomes data specific to postmenopausal women on GLP-1 drugs remain an active research area
Dietary composition, particularly carbohydrates, fats, proteins, and fibre, significantly influences GLP-1 secretion from intestinal L-cells
Note: These statements refer to preliminary research and have not been evaluated by the TGA
Cellular Regeneration & Repair It is thought that the peptide Epitalon helps cells grow new cells by increasing the production of proteins that control how cells divide and work
However, as these medications become more widely adopted, insurers face new challenges in assessing risks and managing long-term health outcomes